rethinkPeptides Search
Menu
Home / Research library
Study breakdown

Do GLP-1 Drugs Help After Bariatric Surgery? Systematic Review and Meta-Analysis

RPEP-148822026Bilal, Abdur Rafay; Ibrahim, Muhammad; Arfin, S M Washaqul; Bilal, Abdur Raheem; Balach, Rahul; Qureshi, Shaheer; Gaba, Hateem; Collins, Peter; Ahmed, Raheel; Waqas, Saad Ahmed
evidence
The takeaway

Meta-analysis of RCTs finds GLP-1 receptor agonists promote additional weight loss and metabolic improvements in patients who have already undergone bariatric surgery.

Additive benefits confirmed

GLP-1 RAs improved weight, BMI, and metabolic markers beyond surgery alone in RCTs

What the researchers found

GLP-1 RAs post-bariatric surgery promoted additional weight loss and improved metabolic markers including BMI, cholesterol, triglycerides, fasting glucose, blood pressure, and HbA1c compared to placebo.

Why it matters

Weight recurrence after bariatric surgery affects 20-30% of patients. GLP-1 drugs could provide a pharmacological rescue strategy for surgical patients who aren't achieving optimal outcomes.

How the study worked

Systematic review and meta-analysis of RCTs from PubMed, Cochrane CENTRAL, and Scopus through March 2025, comparing GLP-1 RA to placebo in post-bariatric surgery patients.

What this study cannot tell us

Limited number of RCTs available. Heterogeneity in surgical procedures, GLP-1 agents, timing of drug initiation, and follow-up periods.

How to read the evidence

Systematic review and meta-analysis of RCTs — high-quality evidence synthesis, limited by small number of available trials.

When this study was published

Published in 2026; includes trials through March 2025.

The bigger picture

The combination of bariatric surgery and GLP-1 pharmacotherapy may represent the most effective obesity treatment strategy available, addressing the limitations of each approach alone.

Questions still open

  • When is the optimal time to start GLP-1 drugs after bariatric surgery?
  • Which bariatric procedure benefits most from adjunct GLP-1 therapy?

Common questions

Can I take GLP-1 drugs after weight loss surgery?
Yes — this meta-analysis shows GLP-1 receptor agonists provide additional weight loss and metabolic benefits after bariatric surgery. They may be especially helpful for patients experiencing weight regain.
Why would someone need medication after bariatric surgery?
About 20-30% of bariatric surgery patients experience weight recurrence. GLP-1 drugs can help these patients achieve and maintain their weight loss goals while also improving blood sugar and cholesterol.

Read the original research

Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists Following Bariatric Surgery: A Systematic Review and Meta-Analysis.

Endocrinology, diabetes & metabolism, 9(2), e70102

View on PubMed ↗Publisher’s paper ↗

Citation

Bilal, Abdur Rafay; Ibrahim, Muhammad; Arfin, S M Washaqul; Bilal, Abdur Raheem; Balach, Rahul; Qureshi, Shaheer; Gaba, Hateem; Collins, Peter; Ahmed, Raheel; Waqas, Saad Ahmed. (2026). Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists Following Bariatric Surgery: A Systematic Review and Meta-Analysis.. Endocrinology, diabetes & metabolism, 9(2), e70102. https://doi.org/10.1002/edm2.70102